Tamer I. Khayal, Chief Commercial Officer at TransMedics Group, Inc. (TMDX), sold 64,760 shares at $105.96 ($7.1M) on 2024-05-01, disclosed to the SEC on 2024-05-03.
Scheduled sale ($7.1M) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.96 | 23,231 | $2.5M | 34.5% |
| 2 | $107.84 | 3,477 | $375K | 5.3% |
| 3 | $109.28 | 3,027 | $331K | 4.6% |
| 4 | $109.83 | 15,892 | $1.7M | 24.5% |
| 5 | $110.06 | 6,888 | $758K | 10.6% |
| 6 | $117.96 | 738 |
| $87K |
| 1.2% |
| 7 | $118.93 | 1,259 | $150K | 2.1% |
| 8 | $119.85 | 1,799 | $216K | 3.0% |
| 9 | $120.01 | 7,388 | $887K | 12.4% |
| 10 | $120.86 | 512 | $62K | 0.9% |
| 11 | $121.74 | 532 | $65K | 0.9% |
| 12 | $122.51 | 17 | $2K | 0.0% |
| Total | $110.23 avg | 64,760 | $7.1M | 100% |
| Filing → |
| TMDX | SELL | 2024-12-04 | $187K | — | Filing → |
| TMDX | SELL | 2024-11-13 | $263K | — | Filing → |
| TMDX | SELL | 2024-11-05 | $179K | — | Filing → |